Marketing Sales and Support Sample Clauses

Marketing Sales and Support. Collaboration Product will be ---------------------------- exclusively marketed, sold and supported (including service, customer training and application support) through the marketing, sales and service organizations of PEB, its Affiliates and distributors, in accordance with a marketing plan to be developed by PEB in consultation with Illumina. Budgets for marketing, sales, and support activities relating to Collaboration Product will be subject to the approval of the Joint Steering Committee. Unless decided otherwise by the Joint Steering Committee, Sales and Marketing Cost will be at least 15% of annual Net Sales but no more than 30% of annual Net Sales. Marketing literature dedicated to Collaboration Product will be marked so as to indicate that the ____________________ [*] CERTAIN INFORMATION ON THIS PAGE HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. Collaboration Product is a product of both PEB and Illumina, and PEB and Illumina will be referenced in the dedicated marketing literature with equal prominence.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Marketing Sales and Support. In order to effectively market Licensed Product(s) the Parties agree that: 3.2.1. Licensed Product(s) will be exclusively marketed, sold and supported (including customer training and application support of customers) through the sales and service organization of Perkxx-Xxxxx, xxs Affiliates and distributors, in accordance with a marketing plan to be developed by Perkxx-Xxxxx. [*] CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
Sample 1
Marketing Sales and Support. IVB agrees to use [**] efforts to market, promote and solicit orders for the Enterprise Platform, whether on a stand-alone basis or as part of a Composite Product, in a manner that reflects favorably on the good will and reputation of the parties. IVB, [**], shall maintain adequate supplies of promotional materials and documentation to promote and sell the Enterprise Platform in accordance with this Agreement. Except as authorized by GMI in writing, IVB will not make or publish any representation, warranty or guarantee on behalf of GMI or its licensors concerning the Enterprise Platform not set forth in the Documentation. IVB will promptly inform GMI of any problems or errors in the Enterprise Platform of which it becomes aware. GMI will use [**] efforts to provide to IVB [**] versions of new releases of the Enterprise Platform at least [**] prior to the date that such software becomes generally available and IVB will make [**] efforts to achieve [**] with GMI's new releases of the Enterprise Platform within [**] after the date such software becomes generally available.
Sample 1
Marketing Sales and Support. In order to effectively market a Collaboration Product the Parties agree that: 3.2.1. a Collaboration Product will be exclusively marketed, sold and supported (including customer training and application support of customers) through the sales and service organization of PERKXX-XXXXX, xxs Affiliates and distributors, in accordance with a marketing plan to be developed by PERKXX-XXXXX; 3.2.2. PERKXX-XXXXX xxxl be responsible for all expenses for the marketing, sales and support of a Collaboration Product; and 3.2.3. Microfluidic Electrophoresis Devices, HTS Systems, and related marketing literature will be marked so as to indicate that such devices are a product of both PERKXX-XXXXX xxx ACLARA.
Sample 1
Marketing Sales and Support 
Sample 1Sample 2Sample 3See All (23)

Related to Marketing Sales and Support

  • Marketing Services The Manager shall provide advice and assistance in the marketing of the Vessels, including the identification of potential customers, identification of Vessels available for charter opportunities and preparation of bids.

  • Product Sales Subject to Sections 10.3(c) and 10.3(d), Licensee agrees that it will not sell, offer for sale, or assist third parties (including Affiliates) in selling Product except for the sale and offer for sale of (A) TAF Product, TAF Combination Product, TDF Product and TDF Combination Product for use in the Field and in the countries of the TDF-TAF Territory, (B) COBI Product and COBI Combination Product for use in the Field and in the countries of the COBI Territory, and (C) EVG Product, EVG Combination Product and Quad Product for use in the Field and in the countries of the EVG-Quad Territory.‌ (i) Licensee agrees that during the period in which the Patents are valid and enforceable (on a Product-by-Product basis) it will prohibit its Distributors from selling Product (A) to any other wholesaler or distributor, (B) outside the Territory for which Licensee is licensed for sale of such Product pursuant to Section 2.2, or (C) for any purpose outside the Field. (ii) Licensee agrees that it will not administer the TAF Quad to humans, or sell the TAF Quad until Gilead has obtained marketing approval for the TAF Quad from the FDA. Licensee agrees that it will not administer EVG to humans, or sell Products containing EVG until Gilead has obtained marketing approval for an EVG Product from the FDA. Licensee agrees that it will not administer COBI to humans, or sell Products containing COBI until Gilead has obtained marketing approval for a COBI Product from the FDA. Licensee agrees that it will not administer TAF to humans, or sell Products containing TAF until Gilead has obtained marketing approval for a TAF Product from the FDA. If Gilead obtains marketing approval from the FDA for any Quad Product or a Combination Product containing TAF, COBI or EVG (“Approved Combination Product”) prior to obtaining marketing approval for a TAF Product, EVG Product or COBI Product from the FDA, then Licensee will be allowed to administer such Quad Product or such Approved Combination Product to humans, and sell such Quad Product or such Approved Combination Product from and after the date of such marketing approval from the FDA, but will not (A) administer to humans or sell Combination Products containing EVG other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for an EVG Product, or (B) administer to humans or sell Combination Products containing COBI other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for a COBI Product or (C) administer to humans or sell Combination Products containing TAF other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for a TAF Product.

  • Non-Marketing Purposes Enertech Information Systems, Inc. greatly respects your privacy. We do maintain and reserve the right to contact you if needed for non-marketing purposes (such as bug alerts, security breaches, account issues, and/or changes in Enertech Information Systems, Inc. products and services). In certain circumstances, we may use our website, newspapers, or other public means to post a notice. Enertech Information Systems, Inc.'s website is not directed to, and does not knowingly collect personal identifiable information from, children under the age of thirteen (13). If it is determined that such information has been inadvertently collected on anyone under the age of thirteen (13), we shall immediately take the necessary steps to ensure that such information is deleted from our system's database, or in the alternative, that verifiable parental consent is obtained for the use and storage of such information. Anyone under the age of thirteen (13) must seek and obtain parent or guardian permission to use this website.

  • Marketing Support Planet Payment will provide such marketing support as Acquirer may reasonably require in connection with marketing the Acquirer Program to Merchants, including but not limited to: (a) The participation of Planet Payment personnel at meetings (if available) or conference calls with Merchants; (b) Assistance in the creation of collateral materials; (c) Assistance in the drafting of contractual agreements and addenda for Acquirers; (d) Assistance in training Merchants in the use of Planet Payment’s systems and reports, which will be made available to them under the Acquirer Program and the operation of the Acquirer Program, including but not limited to use of Planet Payment’s MWEB on-line reporting system and providing suitable training materials.

  • Marketing Plan The MCOP shall submit an annual marketing plan to ODM including all planned activities for promoting membership in or increasing awareness of the MCOP. The marketing plan submission shall include an attestation by the MCOP that the plan is accurate and is not intended to mislead, confuse, or defraud the eligible individuals or ODM.

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Marketing Plans Contractor and the Exchange recognize that Enrollees and other health care consumers benefit from efforts relating to outreach activities designed to increase heath awareness and encourage enrollment. The parties shall share marketing plans on an annual basis and with respect to periodic updates of material changes. The marketing plans of each of the Exchange and Contractor shall include proposed marketing approaches and channels and shall provide samples of any planned marketing materials and related collateral as well as planned, and when completed, expenses for the marketing budget. The Contractor shall include this information for both the Exchange and the outside individual market. The Exchange shall treat all marketing information provided under this Section as confidential information and the obligation of the Exchange to maintain confidentiality of this information shall survive termination or expiration of this Agreement.

  • Contract Sales Price The total consideration provided for in the sales contract for the sale of a Property.

  • CONTRACT SALES REPORTING Contractor shall report total contract sales quarterly to Enterprise Services, as set forth below.

  • Additional Products and Services Subject to the allocation of funds, the CPO may add similar equipment, supplies, services, or locations, within the scope of this Agreement, to the list of equipment, supplies, services, or locations to be performed or provided by giving written notification to Contractor. For purposes of this Section, the “Effective Date” means the date specified in the notification from the CPO. As of the Effective Date, each item added is subject to this Agreement, as if it had originally been a part, but the charge for each item starts to accrue only on the Effective Date. In the event the additional equipment, supplies, services, or locations are not identical to the items(s) already under this Agreement, the charges therefor will then be Contractor’s normal and customary charges or rates for the equipment, supplies, services, or locations classified in the Fees and Costs (Exhibit “F”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!